Ronald E. Cannon

1.8k citations

49 papers · 1.5k indexed · h-index 25

Neurology top 10%
- Barrier Structure and Function Studies 4
Oncology top 10%
- Drug Transport and Resistance Mechanisms 18
Molecular Biology top 10%
- Sphingolipid Metabolism and Signaling 4
- Cancer therapeutics and mechanisms 3
Health, Toxicology and Mutagenesis top 5%
Cancer Research
Genetics
- Virus-based gene therapy research 6
Nutrition and Dietetics
- Trace Elements in Health 5
Pediatrics, Perinatology and Child Health
- Pharmacological Effects and Toxicity Studies 4
Public Health, Environmental and Occupational Health
- Pregnancy and Medication Impact 3

Co-authors: David S. Miller Christopher Campos John G. Scandalios Raymond W. Tennant Guang‐Jer Wu Carol S. Trempus Birandra K. Sinha Joseph White
Cited by: Neurology Oncology Molecular Biology
Journals: Molecular Carcinogenesis (4 papers)Journal of Cerebral Blood Flow & Metabolism (3 papers)Proceedings of the National Academy of Sciences (3 papers)
Partner nations: United States Australia Canada

In The Last Decade

Ronald E. Cannon

49 papers receiving 1.5k citations

Peers

Countries citing papers authored by Ronald E. Cannon

Since Specialization

Citations

This map shows the geographic impact of Ronald E. Cannon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ronald E. Cannon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ronald E. Cannon more than expected).

Fields of papers citing papers by Ronald E. Cannon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ronald E. Cannon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ronald E. Cannon. The network helps show where Ronald E. Cannon may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Ronald E. Cannon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ronald E. Cannon Line = papers co-authored together Ronald E. Cannon links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Nongenomic ERα-AMPK Signaling Regulates Sex-Dependent Bcrp Transport Activity at the Blood-Brain Barrier Endocrinology ·Min Zan,Sue Yarde,Ronald E. Cannon,Kenneth S. Korach	2024	2
2	Ferroptosis-Mediated Cell Death Induced by NCX4040, The Non-Steroidal Nitric Oxide Donor, in Human Colorectal Cancer Cells: Implications in Therapy Cells ·Birandra K. Sinha,Carl D. Bortner,Alan K. Jarmusch,Erik J. Tokar,Luo Rubai,Xian Wu,Heather Winter,Ronald E. Cannon	2023	13
3	Effect of GenX on P-Glycoprotein, Breast Cancer Resistance Protein, and Multidrug Resistance–Associated Protein 2 at the Blood–Brain Barrier Environmental Health Perspectives ·Ronald E. Cannon,Christopher Brightling,Emil Milanov,P.G. Osborne,Birandra K. Sinha,Gabriel A. Knudsen,Linda S. Birnbaum	2020	34
4	Reversal of drug resistance by JS-K and nitric oxide in ABCB1- and ABCG2-expressing multi-drug resistant human tumor cells Biomedicine & Pharmacotherapy ·Birandra K. Sinha,L. Perera,Ronald E. Cannon	2019	20
5	Ceramide 1-Phosphate Increases P-Glycoprotein Transport Activity at the Blood-Brain Barrier via Prostaglandin E2 Signaling Molecular Pharmacology ·Emily V. Mesev,David S. Miller,Ronald E. Cannon	2017	24
6	Selective induction of P-glycoprotein at the CNS barriers during symptomatic stage of an ALS animal model Neuroscience Letters ·Laura Hode,Rebecca A. Evans,Min Zan,Emily V. Mesev,David S. Miller,Ronald E. Cannon	2016	33
7	Effects of Deep Hypothermic Circulatory Arrest on the Blood Brain Barrier in a Cardiopulmonary Bypass Model – A Pilot Study Heart Lung and Circulation ·Karsten Bartels,Qing Ma,Talaignair N. Venkatraman,Christopher Campos,Lindsay K Smith,Ronald E. Cannon,Mihai V. Podgoreanu,Christopher D. Lascola,David S. Miller,Joseph P. Mathew	2014	19
8	Nrf2 Upregulates ATP Binding Cassette Transporter Expression and Activity at the Blood-Brain and Blood-Spinal Cord Barriers Journal of Neuroscience ·Anna Sonnefeld,Christopher Campos,A Hattori,Lindsay K Smith,Piotr Stryszowski,Ronald E. Cannon,David S. Miller	2014	133
9	A Cytogenetic Abnormality and Rare Coding Variants Identify ABCA13 as a Candidate Gene in Schizophrenia, Bipolar Disorder, and Depression The American Journal of Human Genetics ·Helen Miranda Knight,Ben Pickard,Alan Maclean,M. P. Malloy,Dinesh C. Soares,Allan F. McRae,Alison Condie,Angela White,William E. Hawkins,Kevin A. McGhee,M. Van Beck,Donald J. MacIntyre,John M. Starr,Ian J. Deary,Peter M. Visscher,David J. Porteous,Ronald E. Cannon,David St Clair,Walter Muir,Douglas Blackwood	2009	88
10	Identification of a Specific Motif of the DSS1 Protein Required for Proteasome Interaction and p53 Protein Degradation Journal of Molecular Biology ·Sung‐Jen Wei,Jason G. Williams,Hong Dang,Thomas A. Darden,Bryan L. Betz,Margaret M. Humble,R. Sieburger,Carol S. Trempus,Mohammad Mohmoud Abd-Alhaseeb,Ronald E. Cannon,Raymond W. Tennant	2008	37
11	Gene–Environment Interactions: Fundamentals of Ecogenetics Environmental Health Perspectives ·Ronald E. Cannon	2006	5
12	Strong synergy between mutant ras and HPV16 E6/E7 in the development of primary tumors Oncogene ·Karin Schreiber,Ronald E. Cannon,Theodore Karrison,Gabriele Beck‐Engeser,Dezheng Huo,Raymond W. Tennant,真之宮田,W. Martin Kast,Thomas Krausz,Stephen C. Meredith,Lieping Chen,Hans Schreiber	2004	28
13	Molecular structure and characterization of a novel murine ABC transporter, Abca13 Gene ·Scott Barros,Raymond W. Tennant,Ronald E. Cannon	2003	18
14	Identification of Dss1 as a 12-O-Tetradecanoylphorbol-13-acetate-responsive Gene Expressed in Keratinocyte Progenitor Cells, with Possible Involvement in Early Skin Tumorigenesis Journal of Biological Chemistry ·Sung‐Jen Wei,Carol S. Trempus,Ronald E. Cannon,Carl D. Bortner,Raymond W. Tennant	2003	31
15	Loss of critical palindromic transgene promoter sequence in chemically induced Tg.AC mouse skin papillomas expressing transgene‐derived mRNA† Molecular Carcinogenesis ·Karol L. Thompson,Barry A. Rosenzweig,Ronald Honchel,Ronald E. Cannon,Kerry T. Blanchard,Raymond E. Stoll,Frank D. Sistare	2001	9
16	Oral administration of dimethylvinyl chloride increases frequency of forestomach papillomas in Tg.AC mice Molecular Carcinogenesis ·Ronald E. Cannon,Farid Abiri,Judson W. Spalding,Carol S. Trempus,Raymond W. Tennant	2000	5
17	Radial Transformation-Associated Recombination Cloning from the Mouse Genome: Isolation of Tg.AC Transgene with Flanking DNAs Genomics ·Michael C. Humble,Natalya Kouprina,Vladimir N. Noskov,Joan P. Graves,B. R. Toskey,Raymond W. Tennant,Michael A. Resnick,Vladimir Larionov,Ronald E. Cannon	2000	15
18	Association of v-Ha-ras Transgene Expression with Development of Erythroleukemia in Tg.AC Transgenic Mice American Journal Of Pathology ·Carol S. Trempus,Sandra Ward,Georgia M. Farris,David E. Malarkey,Vytautas Mikalauskas,Ronald E. Cannon,Joel F. Mahler	1998	14
19	Comparative Expression of Novel Vascular Endothelial Growth Factor/Vascular Permeability Factor Transcripts in Skin, Papillomas, and Carcinomas of v-Ha-rasTg.AC Transgenic Mice and FVB/N Mice Biochemical and Biophysical Research Communications ·Kathleen L. Tober,Ronald E. Cannon,Judson W. Spalding,Tatiana M. Oberyszyn,Michelle L. Parrett,H Nakhai,Márcia BERGMANN,Fredika M. Robertson	1998	32
20	Kinetics of wound-induced v-Ha-ras transgene expression and papilloma development in transgenic Tg.AC mice Molecular Carcinogenesis ·Ronald E. Cannon,Judson W. Spalding,Carol S. Trempus,C Anna-iris,Akim Tolkachev,Michael C. Humble,Raymond W. Tennant	1997	40

About Ronald E. Cannon

Ronald E. Cannon is a scholar working on Oncology, Neurology, Molecular Biology, Cancer Research and Nutrition and Dietetics, having authored 49 papers that have together received 1.5k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (18 papers), Virus-based gene therapy research (6 papers), Trace Elements in Health (5 papers), Sphingolipid Metabolism and Signaling (4 papers), Barrier Structure and Function Studies (4 papers), Pharmacological Effects and Toxicity Studies (4 papers), Cancer therapeutics and mechanisms (3 papers) and Pregnancy and Medication Impact (3 papers). The work is most often cited by research in Neurology (132 citations), Oncology (422 citations), Molecular Biology (783 citations), Health, Toxicology and Mutagenesis (156 citations) and Cancer Research (156 citations). Ronald E. Cannon has collaborated with scholars based in United States, Australia and Canada. Frequent co-authors include David S. Miller, Christopher Campos, John G. Scandalios, Raymond W. Tennant, Guang‐Jer Wu, Carol S. Trempus, Birandra K. Sinha, Joseph White, Brian T. Hawkins and Lindsay K Smith. Their work appears in journals such as Molecular Carcinogenesis, Journal of Cerebral Blood Flow & Metabolism, Proceedings of the National Academy of Sciences, Toxicological Sciences and Environmental Health Perspectives.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact